Tautomer is a privately owned, fully integrated Health Technology company based in Centurion, South Africa.
Through our network of strategic partners, we engage in the development, manufacturing, and distribution of high-quality Nuclear Medicine based therapies and diagnostics.
Our primary focus in healthcare is to address the unmet medical needs in Oncology, Pain Management, Infectious diseases.
The longer-lived mother radionuclide 188W is adsorbed on the column material while the daughter radionuclide 188Re is selectively eluted from the generator with sterile isotonic solution as sodium perrhenate (Na188ReO4) in volumes indicated in the specification. This enables its use either for radiolabeling reactions or directly as a high dose liquid radioactive source.
It is important to note that sodium perrhenate is not an approved pharmaceutical product, and it is therefore not for human use.
Rhenium -SCT (Skin Cancer Therapy)
Rhenium-188 has a half-life of 17 hours and radiates with a beta decay energy of maximum 2.12 MeV, which enables the treatment of lesions up to a depth of 3 mm .
Rhenium SCT is indicated for the treatment of Basal Cell carcinoma (BCC) and Squamous cell carcinoma (SCC) for patients with co-morbidities for which a surgical approach is not indicated, or for lesions whose anatomical position may result in a suboptimal clinical result. Rhenium SCT® is also indicated for BCC and SCC cases where conventional therapies have failed.
Additional Special Indications:
Our Contact Details
+2712 664 7110
260 Cradock Avenue Lyttelton Manor, Centurion 0157